GlaxoSmithKline (GSK) stock Forecast for 2022, 2023, 2024, 2025

The forecast has been updated: January 18, 2022 14:08


GlaxoSmithKline stock price online today

Analyst Target Price

46.27

Dividend Date

13.01.2022

Ex Dividend Date

18.11.2021

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell GlaxoSmithKline stock today? What is the projected target price level for over the horizon of a year, two, three? How much will be worth in 2021, 2023, 2024?

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Below you can see the results of forecasts for the month, current and future years. Find out target values for stocks, optimistic and pessimistic forecasts.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $46.27 target price for GlaxoSmithKline stock stock.

Today 200 Day Moving Average is the resistance level (40.14 $).

50 Day Moving Average is the resistance level (42.87 $).




GlaxoSmithKline stock monthly Forecast

Date Rate Forecast MIN Rate MAX Rate Volati-
lity, %
20 Jan 22 45.53 45.27 45.71 0.98 %
21 Jan 22 45.40 45.20 45.62 0.94 %
22 Jan 22 45.27 44.93 45.39 1.04 %
23 Jan 22 45.46 45.07 45.85 1.74 %
24 Jan 22 45.49 45.23 45.92 1.53 %
25 Jan 22 45.95 45.83 46.07 0.52 %
26 Jan 22 46.17 45.99 46.49 1.08 %
27 Jan 22 46.22 45.98 46.34 0.77 %
28 Jan 22 46.33 45.92 46.51 1.27 %
29 Jan 22 46.45 46.31 46.73 0.91 %
30 Jan 22 46.12 45.95 46.41 1.00 %
31 Jan 22 46.46 46.17 46.66 1.06 %
01 Feb 22 46.48 46.24 46.87 1.38 %
02 Feb 22 46.24 45.81 46.49 1.49 %
03 Feb 22 45.97 45.81 46.18 0.81 %
04 Feb 22 46.26 45.84 46.65 1.77 %
05 Feb 22 46.10 45.92 46.52 1.33 %
06 Feb 22 46.35 46.00 46.49 1.08 %
07 Feb 22 45.85 45.49 46.19 1.54 %
08 Feb 22 46.05 45.75 46.46 1.57 %
09 Feb 22 46.01 45.67 46.30 1.37 %
10 Feb 22 46.14 45.88 46.28 0.86 %
11 Feb 22 46.35 46.24 46.51 0.59 %
12 Feb 22 46.42 46.29 46.69 0.87 %
13 Feb 22 46.55 46.20 46.91 1.52 %
14 Feb 22 46.82 46.47 47.23 1.63 %
15 Feb 22 46.43 46.17 46.74 1.22 %
16 Feb 22 45.90 45.66 46.26 1.31 %
17 Feb 22 45.70 45.32 45.90 1.28 %
18 Feb 22 45.20 45.07 45.57 1.11 %

GSK daily forecast for this month


GlaxoSmithKline stock forecast for 20.01.2022.
Estimated Average Forecasted GlaxoSmithKline Price: 45.53 Positive intraday dynamics of the instrument is expected with 0.968% volatility is expected.

Pessimistic forecast: 45.27

Optimistic: 45.71


GlaxoSmithKline stock forecast for 21.01.2022.
Estimated Average Forecasted GlaxoSmithKline Price: 45.40 Negative intraday dynamics of the instrument is expected with 0.931% volatility is expected.

Pessimistic forecast: 45.20

Optimistic: 45.62


GlaxoSmithKline stock forecast for 22.01.2022.
Estimated Average Forecasted GlaxoSmithKline Price: 45.27 Negative intraday dynamics of the instrument is expected with 1.029% volatility is expected.

Pessimistic forecast: 44.93

Optimistic: 45.39


GlaxoSmithKline stock forecast for 23.01.2022.
Estimated Average Forecasted GlaxoSmithKline Price: 45.46 Positive intraday dynamics of the instrument is expected with 1.713% volatility is expected.

Pessimistic forecast: 45.07

Optimistic: 45.85


GlaxoSmithKline stock forecast for 24.01.2022.
Estimated Average Forecasted GlaxoSmithKline Price: 45.49 Positive intraday dynamics of the instrument is expected with 1.510% volatility is expected.

Pessimistic forecast: 45.23

Optimistic: 45.92


GSK Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Feb 46.04 45.41 47.28 3.95 %
Mar 46.06 44.80 46.71 4.08 %
Apr 45.65 45.01 46.13 2.43 %
May 46.20 44.95 47.57 5.49 %
Jun 44.81 44.04 45.95 4.15 %
Jul 45.21 44.63 45.71 2.35 %
Aug 46.38 45.24 47.10 3.96 %
Sep 46.21 45.55 46.75 2.58 %
Oct 46.47 45.52 47.19 3.53 %
Nov 46.14 45.58 47.15 3.32 %
Dec 46.16 45.19 46.97 3.79 %

GlaxoSmithKline stock forecast for this year


GlaxoSmithKline share price average forecast for Feb 2022 is: 46.0412 The dynamics are positive.
GlaxoSmithKline share price average forecast for Mar 2022 is: 46.0592 The dynamics are positive.
GlaxoSmithKline share price average forecast for Apr 2022 is: 45.646 The dynamics are negative.
GlaxoSmithKline share price average forecast for May 2022 is: 46.1979 The dynamics are positive.
GlaxoSmithKline share price average forecast for Jun 2022 is: 44.8106 The dynamics are negative.
GlaxoSmithKline share price average forecast for Jul 2022 is: 45.2125 The dynamics are positive.
GlaxoSmithKline share price average forecast for Aug 2022 is: 46.3763 The dynamics are positive.
GlaxoSmithKline share price average forecast for Sep 2022 is: 46.2135 The dynamics are negative.
GlaxoSmithKline share price average forecast for Oct 2022 is: 46.4658 The dynamics are positive.
GlaxoSmithKline share price average forecast for Nov 2022 is: 46.1397 The dynamics are negative.
GlaxoSmithKline share price average forecast for Dec 2022 is: 46.1577 The dynamics are positive.


GlaxoSmithKline stock Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 44.47 44.10 45.82 3.75 %
Feb 44.26 43.57 45.26 3.74 %
Mar 45.43 44.23 45.96 3.78 %
Apr 47.17 46.73 48.36 3.39 %
May 46.49 45.85 46.90 2.24 %
Jun 47.30 46.68 48.15 3.06 %
Jul 49.07 48.35 50.09 3.48 %
Aug 50.03 49.46 50.79 2.61 %
Sep 48.84 47.35 49.55 4.42 %
Oct 48.06 47.61 48.45 1.74 %
Nov 47.12 46.50 48.08 3.29 %
Dec 45.65 45.01 46.92 4.06 %

GlaxoSmithKline stock Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 45.97 44.68 46.73 4.37 %
Feb 45.56 44.65 45.97 2.86 %
Mar 45.90 44.70 46.36 3.59 %
Apr 45.31 44.44 46.28 3.97 %
May 46.03 44.90 47.20 4.87 %
Jun 46.70 45.62 47.62 4.21 %
Jul 46.26 44.92 46.78 3.97 %
Aug 45.63 44.56 46.21 3.58 %
Sep 45.50 44.70 46.82 4.51 %
Oct 44.92 44.01 46.00 4.34 %
Nov 45.34 44.74 46.73 4.28 %
Dec 45.66 44.23 46.40 4.68 %



GlaxoSmithKline stock Forecast for 2025

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 45.25 43.96 45.72 3.86 %
Feb 45.14 43.91 46.00 4.55 %
Mar 46.23 45.87 46.83 2.04 %
Apr 46.39 45.33 47.01 3.58 %
May 45.40 44.05 46.46 5.18 %
Jun 45.84 44.97 46.83 3.97 %
Jul 46.36 45.75 47.19 3.06 %
Aug 45.60 44.41 46.69 4.88 %
Sep 45.80 45.19 46.55 2.92 %
Oct 46.62 45.24 47.85 5.47 %
Nov 47.60 46.67 48.19 3.16 %
Dec 47.51 47.01 48.84 3.76 %

GlaxoSmithKline stock Forecast for 2026

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 48.21 46.86 49.30 4.96 %
Feb 49.49 48.74 51.01 4.46 %
Mar 50.67 50.00 51.65 3.21 %
Apr 51.02 49.81 52.61 5.33 %
May 49.11 48.00 50.26 4.50 %
Jun 49.11 48.65 50.43 3.53 %
Jul 49.76 48.79 50.91 4.16 %
Aug 48.04 47.51 48.62 2.27 %
Sep 47.10 45.87 48.31 5.06 %
Oct 46.44 45.77 46.85 2.32 %
Nov 47.40 46.79 48.19 2.92 %
Dec 48.34 47.93 48.89 1.97 %

GlaxoSmithKline overview

GlaxoSmithKline Address

980 GREAT WEST ROAD, BRENTFORD MIDDLESEX, GB

Market Capitalization

112 812 950 000 $

EBITDA

10 230 000 000

PE Ratio

19.34

PEG Ratio

3.662

Dividend Per Share

0.8

Dividend Yield

0.0491

EPS

2.318

Quarterly Earnings Growth YOY

-0.065

Quarterly Revenue Growth YOY

0.05

Trailing PE

19.34

Forward PE

14.1

EV To Revenue

4.095

EV To EBITDA

12.36

52 Week High

45.08

52 Week Low

32.26

50 Day Moving Average

42.87

200 Day Moving Average

40.14

Shares Outstanding

2515900000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 128.16 (14.01.2022) -1.15 %
AbbVie Inc.
ABBV 135.87 (14.01.2022) 1.76 %
Aeterna Zentaris Inc.
AEZS 0.3597 (14.01.2022) 0.14 %
Allakos Inc.
ALLK 7.64 (14.01.2022) -2.68 %
Allogene Therapeutics, Inc.
ALLO 13.28 (14.01.2022) 11.04 %
Amgen Inc.
AMGN 235.36 (14.01.2022) 1.95 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 16.07 (14.01.2022) 12.93 %
Aurora Cannabis Inc.
ACB 5.51 (14.01.2022) -0.54 %
Becton Dickinson and Company
BDX 262.62 (14.01.2022) -0.41 %
Biogen Inc.
BIIB 239.3 (14.01.2022) 1.11 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 122.17 (14.01.2022) -0.46 %
BioNTech SE
BNTX 196 (14.01.2022) -3.44 %
bluebird bio, Inc.
BLUE 8.73 (14.01.2022) 2.46 %
Boston Scientific Corp.
BSX 44.86 (14.01.2022) 0.65 %
Bristol-Myers Squibb Company
BMY 64.93 (14.01.2022) 0.51 %
Canopy Growth Corp.
CGC 8.4 (14.01.2022) -0.12 %
Castle Biosciences, Inc.
CSTL 36.69 (14.01.2022) -0.73 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 244.12 (14.01.2022) -2.22 %
Emergent BioSolutions Inc.
EBS 52.22 (14.01.2022) 5.54 %
Exelixis, Inc.
EXEL 18.12 (14.01.2022) 1.97 %
G1 Therapeutics, Inc.
GTHX 10.11 (14.01.2022) 6.42 %
Gilead Sciences, Inc.
GILD 71.77 (14.01.2022) -0.15 %
GlaxoSmithKline plc
GSK 45.47 (14.01.2022) 0.91 %
GoodRx Holdings, Inc.
GDRX 26.85 (14.01.2022) -1.32 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 74.88 (14.01.2022) 1.67 %
Inovio Pharmaceuticals, Inc.
INO 4.75 (14.01.2022) 3.04 %
Johnson & Johnson
JNJ 167.84 (14.01.2022) -0.55 %
Medtronic plc.
MDT 108.55 (14.01.2022) -0.21 %
Merck & Co., Inc.
MRK 81.38 (14.01.2022) 0.07 %
Moderna, Inc.
MRNA 204.73 (14.01.2022) -2.59 %
Novartis AG
NVS 90.55 (14.01.2022) -0.08 %
Novavax, Inc.
NVAX 110.82 (14.01.2022) -1.39 %
ObsEva SA
OBSV 1.92 (14.01.2022) 1.59 %
OrganiGram Holdings Inc.
OGI 1.64 (14.01.2022) -1.20 %
Pfizer Inc.
PFE 54.95 (14.01.2022) -1.06 %
Regeneron Pharmaceuticals, Inc.
REGN 615.24 (14.01.2022) -0.14 %
Sanofi
SNY 51.93 (14.01.2022) 2.37 %
Schrodinger, Inc.
SDGR 30.69 (14.01.2022) 3.40 %
Senseonics Holdings, Inc.
SENS 2.84 (14.01.2022) 2.16 %
Sorrento Therapeutics, Inc.
SRNE 4.56 (14.01.2022) 5.31 %
Stryker Corp.
SYK 266.71 (14.01.2022) -0.44 %
Sundial Growers Inc.
SNDL 0.564 (14.01.2022) 0.64 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 9.17 (14.01.2022) -0.33 %
Thermo Fisher Scientific Inc.
TMO 594.8 (14.01.2022) -1.01 %
Tilray, Inc.
TLRY 6.86 (14.01.2022) -0.15 %
UnitedHealth Group, Inc.
UNH 468.69 (14.01.2022) 0.27 %
Veeva Systems Inc.
VEEV 223.85 (14.01.2022) -1.45 %
Zomedica Corp.
ZOM 0.35 (14.01.2022) 4.45 %
Zynerba Pharmaceuticals, Inc.
ZYNE 2.63 (14.01.2022) 3.14 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.